Sleep Disorders Trial, Recruiting NCT06677268 Sponsor: University Hospital, Rouen Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT06677268
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 50 or older, of any sex
  • People who have been diagnosed with COPD (a chronic lung condition) according to recognised 2022 medical guidelines, whose condition is currently stable (no flare-ups in the last 4 weeks), and who have been recommended for breathing rehabilitation
  • People who have not taken part in a breathing rehabilitation programme in the past 12 months
  • People who are enrolled in the French social security system
  • Women who could potentially become pregnant and have been using effective contraception (such as the pill, an intrauterine device, or tubal ligation) for at least 1 month before joining
  • Women who have gone through menopause, confirmed by having had no periods for at least 12 months without a medical cause
  • People who have read and understood the information provided about the trial and have signed a consent form

Who may not be able to join:

  • People with a Body Mass Index (a measure of body weight relative to height) of 30 or above
  • People who have already been diagnosed with sleep apnoea (a condition where breathing repeatedly stops during sleep) with more than 10 episodes per hour
  • People who currently use a CPAP machine or a breathing support device (non-invasive ventilation)
  • People currently taking steroid tablets or other systemic corticosteroid medicines
  • People currently taking medicines that act on the brain or central nervous system, such as benzodiazepines (e.g. sleeping tablets or anxiety medicines) or opiates (e.g. strong pain relief medicines)
  • People who have had a severe COPD flare-up
  • People who have another long-term breathing or respiratory condition in addition to COPD
  • People currently being treated for active cancer
  • People with a neuromuscular disease (a condition affecting the nerves and muscles)
  • People with a physical disability, injury, or neurological condition that would prevent them from taking part in a breathing rehabilitation programme
  • People with psychiatric, cognitive, or language difficulties that would make it impossible to understand or follow the trial procedures
  • People with any other medical condition or reason that would make breathing rehabilitation unsafe or impossible, including any heart or cardiovascular condition that would rule it out
  • People who are under legal restriction of freedom (for example, detained by an administrative or court order), or who are under legal guardianship or protection measures
  • Women who are pregnant, have recently given birth, or are currently breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: (+33) 0232888265

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University Hospital, Rouen
Registry
ClinicalTrials.gov
Start date
19 February 2025
Est. completion
1 February 2028

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Total sleep time (TST)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov